Thermo Fisher Scientific Inc. has a "Moderate Buy" rating from analysts, with a target price of $632.50. The company's strong quarterly earnings exceeded estimates, and it raised its dividend, despite some insider selling.

NodeGuardian

2026-04-18 02:57:52

Abstract generation in progress

Thermo Fisher Scientific Inc. (NYSE:TMO) has received a “Moderate Buy” consensus rating from twenty-two research firms, with most analysts issuing buy recommendations and an average 12-month target price of $632.50. The company recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. Insider activity shows some selling by executives, while institutional investors have significantly increased their positions in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
203.79K Popularity
#
Gate13thAnniversaryLive
634.51K Popularity
#
AltcoinsRallyStrong
7.33M Popularity
#
AnthropicvsOpenAIHeatsUp
1.07M Popularity
#
KalshiFacesNevadaRegulatoryClash
464.34K Popularity

Sitemap

Thermo Fisher Scientific Inc. (NYSE:TMO) Receives Consensus Rating of "Moderate Buy" from Analysts

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

AltcoinsRallyStrong

AnthropicvsOpenAIHeatsUp

KalshiFacesNevadaRegulatoryClash

Pin